We engineer phototrophic microalgae to redirect carbon flux toward your target product — from lipids and carotenoids to recombinant proteins.
From design to engineered strain — we manage transformation, clone selection, and phototrophic production under controlled conditions.
We combine pathway design, transformation, phototrophic cultivation, and analytical chemistry to deliver custom strains tailored to your target molecule.
Our team designs genetic constructs to overexpress, knock down, or knock in key metabolic genes. We codon‑evaluate for algal hosts and use validated promoters, terminators, and selection markers.
We deliver stable transformants in phototrophic hosts. Screening includes antibiotic selection, fluorescence‑activated cell sorting (FACS) or microtiter‑plate assays to identify high‑producers.
Engineered strains are grown in photobioreactors or shake flasks under defined light, CO₂, and nutrient regimes to evaluate product yield.
We measure target metabolites (lipids, pigments) or proteins by GC‑MS, HPLC, LC‑MS, or enzymatic assays. Culture biomass and media analyzed.
Strains are passaged under non‑selective conditions and re‑evaluated for phenotype and transgene retention. Reports include stability data over ≥10 generations.
Each project concludes with a handoff package containing engineered strains, full analytical data, and a service report.
Every project is defined case‑by‑case. The table below lists typical parameters that are scoped during a consultation.
| Parameter | Typical project scope |
|---|---|
| Host strain(s) | Chlamydomonas reinhardtii (e.g., CC‑124, UVM4), Nannochloropsis oceanica (e.g., CCMP1779, IMET1), or other phototrophic algae as agreed |
| Genetic edit type | Overexpression (gene/cassette insertion), knockdown (RNAi, antisense, CRISPRi), knockout (CRISPR‑Cas9, HR‑based), or knock‑in (precise edits scoped per target) |
| Target product to be engineered | Scoped per project after consultation. |
| Number of constructs / transformations | Typically 1–5 constructs per project; each transformed into 2–3 host strains if needed; higher throughput available on request |
| Clone screening depth | Scoped per project after consultation |
| Cultivation mode | Shake‑flask, 1 L photobioreactor, or custom vessel; phototrophic, mixotrophic, or heterotrophic conditions as scoped |
| Product analysis package | GC‑MS (fatty acids), HPLC (pigments), LC‑MS (metabolites, proteins), enzymatic assays; calibration with commercial standards |
| Genetic stability study | ≥10 serial passages under non‑selective light; re‑testing of product yield and transgene retention; report included |
| Turnaround time | Scoped per project after consultation |
| Technical support | Named scientific contact at project start; milestone review calls; email response within 1 business day |
A streamlined, modular process that adapts to your project goals. Each step is executed in‑house and reviewed at milestones.
We review your target product and proposed pathway, then design custom genetic constructs (promoters, UTRs, selection markers, editing tools). Constructs are assembled and sequence‑verified before transformation.
Constructs are delivered into your chosen host via validated transformation methods. Transformants are selected on solid or liquid medium containing the appropriate antibiotic. Individual colonies are isolated and expanded.
Isolated clones are screened by PCR, qPCR, or Southern blot to confirm integration. Top candidates are assayed for target product accumulation using appropriate analytical methods (GC‑MS, HPLC, fluorescence).
Selected strains are cultivated in replicate bioreactors or shake flasks under controlled light intensity, photoperiod, CO₂, and nutrient feeding. Growth curves and product titers are measured over a defined time course.
The best performing strain(s) undergo serial passaging without selection. After 10+ generations, product yield and transgene presence are.
Our service supports research and early‑stage production across multiple industries.
Engineer algae for elevated triacylglycerol (TAG) accumulation or tailored fatty‑acid profiles for biodiesel, renewable diesel, or aviation fuel.
Introduce or upregulate pathways for astaxanthin, β‑carotene, lutein, or canthaxanthin to serve the supplement, cosmetic, and feed markets.
Express antibodies, enzymes, or growth factors in phototrophic algae. Benefits include low production cost and absence of mammalian pathogens.
We address the most frequent concerns from researchers and biotechnology companies.
We have extensive experience with Chlamydomonas reinhardtii (a model green alga) and several Nannochloropsis species (especially N. oceanica and N. gaditana). Other phototrophic microalgae, such as Phaeodactylum tricornutum or Haematococcus pluvialis, can be accommodated after scoping. We will help you select the best chassis for your target molecule.
Stability is assessed by serially passaging the best clones under non‑selective conditions (light, CO₂, minimal medium) for generations. We re‑measure product yield and confirm transgene presence by PCR or sequencing. Only strains that maintain ≥ project-dependent performance that is verified during development of the initial phenotype are included in the final deliverable. Polyploid / multi‑nucleate hosts (e.g., Chlamydomonas) are flagged, and stable integration is verified.
Absolute yields depend heavily on the target, the host strain, and cultivation conditions (photobioreactor vs shake flask). Our engineering approach aims to achieve industrially relevant improvements, but we cannot guarantee a specific fold‑increase or final titer without a preliminary feasibility study. Acceptance criteria are defined in the project SOW based on your baseline data.
Yes, we include in‑silico off‑target prediction for CRISPR‑Cas9 designs. Targeted amplicon sequencing of predicted off‑target loci can be added as a scoped option. We do not currently perform genome‑wide off‑target profiling (e.g., GUIDE‑seq) for algae, as such assays are not validated for these hosts. Off‑target analysis depth is defined at the project scoping stage.
Most projects are completed a timeline confirmed during project scoping. Complex projects involving knock‑in of large constructs, multi‑gene pathways, or extensive clone screening may take longer. A detailed timeline is provided in the project proposal before work begins.
Get a customized quote for your Algal Metabolic Engineering Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.